|
Delayed
Bombay S.E.
09:05:19 16/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1,930.80 INR | -0.18% |
|
-1.67% | +35.59% |
| 08-14 | Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 08-13 | Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,324.87 | +16.61% | 29 | ||||||
| 277.91 | +4.01% | 22 | ||||||
| 278.61 | +5.92% | 28 | ||||||
| 374.61 | +3.88% | 19 | ||||||
| 153.05 | +10.12% | 22 | ||||||
| 211.86 | +29.67% | 23 | ||||||
| 388.03 | +3.3% | 29 | ||||||
| 310.17 | +12.42% | 23 | ||||||
| 158.15 | +8.1% | 27 | ||||||
| 28.88 | +4.81% | 26 | ||||||
| 569.19 | +10.6% | 27 | ||||||
| 66.71 | +4.67% | 24 | ||||||
| 94.06 | +26.75% | 24 | ||||||
| 21.71 | +17.1% | 21 | ||||||
| 9,323.33 | +43.44% | 15 | ||||||
| 6,603.31 | +12.94% | 16 | ||||||
| 58.22 | +19.53% | 18 | ||||||
| 71.35 | +65.44% | 17 | ||||||
| 4.202 | +23.42% | 17 | ||||||
| Average | 1,069.38 | +16.98% | 22 | ||||||
| Weighted average by Cap. | 716.17 | +12.12% | 25 |
Select your edition
All financial news and data tailored to specific country editions
